Cleveland Clinic 6th Annual Multidisciplinary Colorectal Oncology Course
Metastatic Colon Cancer
Cleveland Clinic 6th Annual Multidisciplinary Colorectal Oncology Course
Nivo +/- Ipi, or Pembro Recommended as 2nd Line for mCRC, Trials on IO vs. Chemo or + Chemo Are Underway for MSI-High mCRC and Adjuvant, Ragorafenib + Nivo Resulted in 36% RR in MSS Disease
FEATURING
Smitha Krishnamurthi
- 1,409 views
- December 10, 2019
- 2
Cleveland Clinic 6th Annual Multidisciplinary Colorectal Oncology Course
Crucial Clinical Trials for Metastatic Colorectal Cancer: PIK3CA CRC Is Sensitive to Glutamine Deprivation, FOLFIRI Bevacizumab +/- Napabucasin Trial, Trials on BRAF Mutant and HER2+ Disease
FEATURING
Smitha Krishnamurthi
- 166 views
- December 10, 2019